Exploring human-genome gut-microbiome interaction in Parkinson's disease

Area of Science:

• Neuroscience
• Microbiology
• Genetics

Background:

• Complex diseases like Parkinson's disease (PD) remain poorly understood despite extensive research.
• Genetic factors and environmental risks have been investigated, but a unifying explanation is lacking.
• The gut microbiome's role in neurodegenerative diseases is an emerging area of study.

Purpose of the Study:

• To investigate the hypothesis that the gut microbiome is a critical factor in the pathogenesis of PD.
• To explore the relationship between host genetics, specifically the alpha-synuclein locus, and gut microbiome dysbiosis in PD.
• To identify potential microbial triggers for PD pathology.

Main Methods:

• Analysis of two large patient datasets.
• Examination of host genetic variants at the alpha-synuclein locus.
• Assessment of gut microbiome composition and abundance, focusing on microbial clusters and opportunistic pathogens.
• Correlation of genetic data with microbiome data.

Main Results:

• Evidence suggests that the overabundance of opportunistic pathogens in the gut of PD patients is influenced by host genotype at the alpha-synuclein locus.
• Specific genetic variants at the alpha-synuclein locus were found to modulate alpha-synuclein expression.
• Altered abundances of microbial clusters, including opportunistic pathogens, were identified in PD patients.

Conclusions:

• The gut microbiome, particularly opportunistic pathogens, may play a significant role in PD pathogenesis.
• Host genetics at the alpha-synuclein locus can influence gut microbiome composition, potentially explaining incomplete penetrance of PD risk genes.
• These findings propose testable hypotheses regarding PD triggers and the interplay between host genetics and the microbiome.